1 / 3

Sponsor

FDA. Electronic Document Room. Biostat Reviewer Doses, Survival Tumor incidence. Carcinogenicity study Study report – pdf (SEND?) Tumor data – xpt (SEND?) 13 week toxicity study Study report – pdf (SEND?) Human PK study Study report – pdf (SDTM?). Sponsor. Pharm/Tox Reviewer

salim
Download Presentation

Sponsor

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FDA Electronic Document Room Biostat Reviewer Doses, Survival Tumor incidence • Carcinogenicity study • Study report – pdf (SEND?) • Tumor data – xpt (SEND?) • 13 week toxicity study • Study report – pdf (SEND?) • Human PK study • Study report – pdf (SDTM?) Sponsor Pharm/Tox Reviewer Tumor incidence with statistical significance Doses, Survival AUCs (animal and human) Result – labeling statement “The NOAEL for tumors in mice was 30 mg/kg or 15 times the exposure in humans at the maximum recommended human dose.” Clin Pharm Reviewer Human Drug Conc.

  2. NOAEL FDA Biostat-generated table

  3. AUC at NOAEL TK parameters from tox study report PK parameter from Clin Pharm Review Human AUC at maximum recommended human dose = 4150 ng∙h/mL Animal to human AUC ratio at NOAEL = 61500 ng∙h/mL  4150 ng∙h/mL= 14.82 ≈ 15

More Related